Article info

Original research
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Authors

  1. Correspondence to Professor Danny Rischin; danny.rischin{at}petermac.org
View Full Text

Citation

Rischin D, Khushalani NI, Schmults CD, et al
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Publication history

  • Accepted June 15, 2021
  • First published August 19, 2021.
Online issue publication 
November 02, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.